Perinatal maternal mental health, fetal programming and child development

Healthcare (Switzerland)

Volumn 3, Issue 4, 2015, Pages 1212-1227

  Lewis, Andrew J ^a   Austin, Emma ^a   Knapp, Rebecca ^a   Vaiano, Tina ^a,b   Galbally, Megan ^b,c  

^a DEAKIN UNIVERSITY   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Child temperament; Cortisol; Epigenetics; Fetal programming; Growth; Mental health in pregnancy; Perinatal depression and anxiety; Placenta

Indexed keywords

EID: 84992543996     PISSN: None     EISSN: 22279032     Source Type: Journal    
DOI: 10.3390/healthcare3041212     Document Type: Review

References (77)

1. Martins, C.; Gaffan, E.A. Effects of early maternal depression on patterns of infant-mother attachment: A meta-analytic investigation. J. Child Psychol. Psychiatry 2000, 41, 737–746.
2. Stein, A.; Pearson, R.M.; Goodman, S.H.; Rapa, E.; Rahman, A.; McCallum, M.; Howard, L.M.; Pariante, C.M. Effects of perinatal mental disorders on the fetus and child. Lancet 2014, 384, 1800–1819.
3. Field, T. Prenatal depression effects on early development: A review. Infant Behav. Dev. 2011, 34, 1–14.
4. Sinclair, K.; Lea, R.; Rees, W.; Young, L. The developmental origins of health and disease: Current theories and epigenetic mechanisms. Soc. Reprod. Fertil. Suppl. 2007, 64, 425–443.
5. Gluckman, P.D.; Hanson, M.A.; Buklijas, T. A conceptual framework for the developmental origins of health and disease. J. Dev. Orig. Health Dis. 2010, 1, 6–18.
6. Ding, X.-X.; Wu, Y.-L.; Xu, S.-J.; Zhu, R.-P.; Jia, X.-M.; Zhang, S.-F.; Huang, K.; Zhu, P.; Hao, J.H.; Tao, F.B. Maternal anxiety during pregnancy and adverse birth outcomes: A systematic review and meta-analysis of prospective cohort studies. J. Affect. Disord. 2014, 159, 103–110.
7. Galbally, M.; Snellen, M.; Lewis, A.J. A review of the use of psychotropic medication in pregnancy. Curr. Opin. Obstet. Gynecol. 2011, 23, 408–414.
8. Buist, A.; Bilszta, J. The beyondblue National Postnatal Screening Program, Prevention and Early Intervention 2001–2005, Final Report Volume I: National Screening Program; Beyondblue: Melbourne, Australia, 2006.
9. Bennett, H.A.; Einarson, A.; Taddio, A.; Koren, G.; Einarson, T.R. Prevalence of depression during pregnancy: Systematic review. Obstet. Gynecol. 2004, 103, 698–709.
10. Gotlib, I.H.; Whiffen, V.E.; Mount, J.H.; Milne, K.; Cordy, N.I. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J. Consult. Clin. Psychol. 1989, 57, 269–274.
11. Andersson, L.; Sundström-Poromaa, I.; Bixo, M.; Wulff, M.; Bondestam, K.; Åstöm, M. Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study. Am. J. Obstet. Gynecol. 2003, 189, 148–154.
12. Howard, L.M.; Molyneaux, E.; Dennis, C.-L.; Rochat, T.; Stein, A.; Milgrom, J. Non-psychotic mental disorders in the perinatal period. Lancet 2014, 384, 1775–1788.
13. Lewis, A.J.; Bailey, C.; Galbally, M. Anti-depressant use during pregnancy in Australia: Findings from the Longitudinal Study of Australian Children. Aust. N. Z. J. Public Health 2012, 36, 487–488.
14. Suzuki, K.; Sato, M.; Zheng, W.; Shinohara, R.; Yokomichi, H.; Yamagata, Z. Effect of maternal smoking cessation before and during early pregnancy on fetal and childhood growth. J. Epidemiol. 2014, 24, 60–66.
15. Novakovic, B.; Ryan, J.; Pereira, N.; Boughton, B.; Craig, J.M.; Saffery, R. Postnatal stability, tissue, and time specific effects of AHRR methylation change in response to maternal smoking in pregnancy. Epigenetics 2014, 9, 377–386.
16. Behnke, M.; Smith, V.C. Prenatal substance abuse: Short-and long-term effects on the exposed fetus. Pediatrics 2013, 131, e1009–e1024.
17. Hoffman, J.D. Pregnancy and Alcohol Consumption; Nova Science Publishers: New York, NY, USA, 2011.
18. Carter, R.C.; Jacobson, J.L.; Sokol, R.J.; Avison, M.J.; Jacobson, S.W. Fetal alcohol-related growth restriction from birth through young adulthood and moderating effects of maternal prepregnancy weight. Alcohol. Clin. Exp. Res. 2013, 37, 452–462.
19. Auttiramo, I.; Gaily, E.; Granstrom, M.L. Dysmorphic features in offspring of alcoholic mothers. Arch. Dis. Child. 1992, 67, 712–716.
20. Hingson, R.; Alpert, J.J.; Day, N.; Dooling, E.; Kayne, H.; Morelock, S.; Oppenheimer, E.; Zuckerman, B. Effects of Maternal drinking and marijuana use on fetal growth and development. Pediatrics 1982, 70, 539–546.
21. Galbally, M.; Gentile, S.; Lewis, A.J. Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: Clinical implications. CNS Drugs 2012, 26, 813–822.
22. Galbally, M.; Lewis, A.J. Prenatal exposure to antidepressants is associated with small but significant differences in pregnancy and delivery outcomes. Evid. Based Ment. Health 2013, doi:10.1136/eb-2013-101405.
23. Galbally, M.; Lewis, A.J.; Buist, A. Developmental outcomes of children exposed to antidepressants in pregnancy. Aust. N. Z. J. Psychiatry 2011, 45, 393–399.
24. Galbally, M.; Lewis, A.; Lum, J.; Buist, A. Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: Prospective controlled study. Aust. N. Z. J. Psychiatry 2009, 43, 846–854.
25. Lewis, A.J.; Galbally, M. Review: Adverse effects of antidepressants use during pregnancy. Evid. Based Ment. Health 2011, doi:10.1136/ebmh.14.2.40.
26. Lewis, A.J.; Galbally, M.; Opie, G.; Buist, A. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust. N. Z. J. Psychiatry 2010, 44, 482–487.
27. Andrade, S.E.; Raebel, M.A.; Brown, J.; Lane, K.; Livingston, J.; Boudreau, D.; Rolnick, S.J.; Roblin, D.; Smith, D.H.; Willy, M.E. Use of antidepressant medications during pregnancy: A multisite study. Am. J. Obstet. Gynecol. 2008, doi:10.1016/j.ajog.2007.07.036.
28. Rodriguez-Bernal, C.L.; Rebagliato, M.; Ballester, F. Maternal nutrition and fetal growth: The role of iron status and intake during pregnancy. Nutr. Diet. Suppl. 2012, 4, 25–37.
29. Robinson, M.; Whitehouse, A.J.O.; Newnham, J.P.; Gorman, S.; Jacoby, P.; Holt, B.J.; Serralha, M.; Tearne, J.E.; Holt, P.G.; Hart, P.H.; et al. Low maternal serum vitamin D during pregnancy and the risk for postpartum depression symptoms. Arch. Womens Ment. Health 2014, 17, 213–219.
30. Wu, G.Y.; Imhoff-Kunsch, B.; Girard, A.W. Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatr. Perinat. Epidemiol. 2012, 26, 4–26.
31. Parsons, T.J.; Power, C.; Manor, O. Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: Longitudinal study. BMJ 2001, doi:10.1136/bmj. 323.7325.1331.
32. Lewis, A.J.; Austin, E.; Galbally, M. Maternal mental health and fetal growth restriction: A systematic review. J. Dev. Orig. Health Dis. Submitted, 2015.
33. Lewis, A.J. Depression in Pregnancy and Child Development: Understanding the Mechanisms of Transmission; Springer: Berlin, Germany, 2014.
34. Lerner, R.M. Concepts and Theories of Human Development; Psychology Press: New York, NY, USA, 2001.
35. Rutter, M.; Sroufe, L. Developmental psychopathology: Concepts and challenges. Dev. Psychopathol. 2000, 12, 265–296.
36. Barker, D.J.P. The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease. Proc. Biol. Sci. 1995, 262, 37–43.
37. Lewis, A.J. A call for an expanded synthesis of developmental and evolutionary paradigms. Behav. Brain Sci. 2012, 35, 368–369.
38. Lewis, A.J.; Galbally, M.; Gannon, T.; Symeonides, C. Early life programming as a target for prevention of child and adolescent mental disorders. BMC Med. 2014, doi:10.1186/1741-7015-12-33.
39. Leung, C.Y.; Leung, G.M.; Schooling, C.M. Early second-hand smoke exposure and child and adolescent mental health: Evidence from Hong Kong’s “Children of 1997” birth cohort. Addiction 2015, 110, 1811–1824.
40. Bertram, C.E.; Hanson, M.A. Prenatal programming of postnatal endocrine responses by glucocorticoids. Reproduction 2002, 124, 459–467.
41. Meaney, M.J. Epigenetics and the biological definition of gene × environment interactions. Child Dev. 2010, 81, 41–79.
42. Galbally, M.; Lewis, A.J.; Ijzendoorn, M.; Permezel, M. The role of oxytocin in mother-infant relations: A systematic review of human studies. Harv. Rev. Psychiatry 2011, 19, 1–14.
43. Evans-Galea, M.V.; Hannan, A.J.; Carrodus, N.; Delatycki, M.B.; Saffery, R. Epigenetic modifications in trinucleotide repeat diseases. Trends Mol. Med. 2013, 19, 655–663.
44. Bird, A. Perceptions of epigenetics. Nature 2007, 447, 396–398.
45. O’Donnell, K.J.; Bugge Jensen, A.; Freeman, L.; Khalife, N.; O’Connor, T.G.; Glover, V. Maternal prenatal anxiety and downregulation of placental 11β-HSD2. Psychoneuroendocrinology 2012, 37, 818–826.
46. Owens, J.A. Endocrine and substrate control of fetal growth: Placental and maternal influences and insulin-like growth factors. Reprod. Fertil. Dev. 1991, 3, 501–517.
47. Barker, D.J. The long-term outcome of retarded fetal growth. Clin. Obstet. Gynecol. 1997, 40, 853–863.
48. Massaro, A.N.; Rothbaum, R.; Aly, H. Fetal brain development: The role of maternal nutrition, exposures and behaviors. J. Pediatr. Neurol. 2006, 4, 1–9.
49. Seth, S.; Lewis, A.J.; Saffery, R.; Lappas, M.; Galbally, M. Maternal prenatal mental health and placental 11b-HSD2 gene expression: Initial findings from the mercy pregnancy and emotional wellbeing study. Int. J. Mol. Sci. 2015, doi:10.3390/ijms161126034.
50. Seckl, J.R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 2004, 151, U49–U62.
51. Seng, J.S.; Rauch, S.A.M.; Resnick, H.; Reed, C.D.; King, A.; Low, L.K.; McPherson, M.; Muzik, M.; Abelson, J.; Liberzon, I. Exploring posttraumatic stress disorder symptom profile among pregnant women. J. Psychosom. Obstet. Gynaecol. 2010, 31, 176–187.
52. Robinson, J.; Chidzanja, S.; Kind, K.; Lok, F.; Owens, P.; Owens, J. Placental control of fetal growth. Reprod. Fertil. Dev. 1995, 7, 333–344.
53. Mulder, E.J.H.; de Medina, P.G.R.; Huizink, A.C.; van den Bergh, B.R.H.; Buitelaar, J.K.; Visser, G.H.A. Prenatal maternal stress: Effects on pregnancy and the (unborn) child. Early Hum. Dev. 2002, 70, 3–14.
54. Zijlmans, M.A.C.; Riksen-Walraven, J.M.; de Weerth, C. Associations between maternal prenatal cortisol concentrations and child outcomes: A systematic review. Neurosci. Biobehav. Rev. 2015, 53, 1–24.
55. Gicquel, C.; le Bouc, Y. Hormonal regulation of fetal growth. Horm. Res. 2006, 65, 28–33.
56. Field, T.; Diego, M.; Hernandez-Reif, M. Prenatal depression effects on the fetus and newborn: A review. Infant Behav. Dev. 2006, 29, 445–455.
57. Simmons, R. Developmental origins of adult metabolic disease: Concepts and contraversies. Trends Endocrinol. Metab. 2005, 16, 390–394.
58. Henrichs, J.; Schenk, J.J.; Roza, S.J.; van den Berg, M.P.; Schmidt, H.G.; Steegers, E.A.; Hofman, A.; Jaddoe, V.W.; Verhulst, F.C.; Tiemeier, H. Maternal psychological distress and fetal growth trajectories: The generation R study. Psychol. Med. 2010, 40, 633–643.
59. El Marroun, H.; Jaddoe, V.W.; Hudziak, J.J.; Roza, S.J.; Steegers, E.A.; Hofman, A.; Verhulst, F.C.; White, T.J.; Stricker, B.H.; Tiemeier, H. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch. Gen. Psychiatry 2012, 69, 706–714.
60. Diego, M.A.; Field, T.; Hernandez-Reif, M.; Schanberg, S.; Kuhn, C.; Gonzalez-Quintero, V.H. Prenatal depression restricts fetal growth. Early Hum. Dev. 2009, 85, 65–70.
61. Diego, M.A.; Jones, N.A.; Field, T.; Hernandez-Reif, M.; Schanberg, S.; Gonzalez-Garcia, A.; Kuhn, C. Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom. Med. 2006, 68, 747–753.
62. Field, T.; Diego, M.A.; Hernandez-Reif, M.; Figueiredo, B.; Ascencio, A.; Schanberg, S.; Kuhn, C. Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth. Depress. Anxiety 2008, 25, E11–E16.
63. Oberlander, T.F. Fetal serotonin signaling: Setting pathways for early childhood development and behavior. J. Adolesc. Health 2012, 51, S9–S16.
64. Lewis, A.J.; Olsson, C.A. Early life stress and child temperament style as predictors of childhood anxiety and depressive symptoms: Findings from the longitudinal study of Australian children. Depress. Res. Treat. 2011, doi:10.1155/2011/296026.
65. Davis, E.P.; Glynn, L.M.; Schetter, C.D.; Hobel, C.; Chicz-Demet, A.; Sandman, C.A. Prenatal exposure to maternal depression and cortisol influences infant temperament. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46, 737–746.
66. Goodman, S.H.; Rouse, M.H.; Connell, A.M.; Broth, M.R.; Hall, C.M.; Heyward, D. Maternal depression and child psychopathology: A meta-analytic review. Clin. Child Fam. Psychol. Rev. 2011, 14, 1–27.
67. Fergusson, D.M.; Lynskey, M.T.; Horwood, L.J. The effect of maternal depression on maternal ratings of child behavior. J. Abnorm. Child Psychol. 1993, 21, 245–269.
68. Durbin, C.E.; Wilson, S. Convergent validity of and bias in maternal reports of child emotion. Psychol. Assess. 2012, 24, 647–660.
69. Lewis, A.J.; Bertino, M.D.; Bailey, C.M.; Skewes, J.; Lubman, D.I.; Toumbourou, J.W. Depression and suicidal behavior in adolescents: A multi-informant and multi-methods approach to diagnostic classification. Front. Psychol. 2014, doi:10.3389/fpsyg.2014.00766.
70. Loomans, E.M.; van der Stelt, O.; van Eijsden, M.; Gemke, R.J.B.J.; Vrijkotte, T.; van den Bergh, B.R. Antenatal maternal anxiety is associated with problem behaviour at age five. Early Hum. Dev. 2011, 87, 565–570.
71. O’Connor, T.G.; Heron, J.; Golding, J.; Glover, V.; the ALSPAC Study Team. Maternal antenatal anxiety and behavioural/emotional problems in children: A test of a programming hypothesis. J. Child Psychol. Psychiatry 2003, 44, 1025–1036.
72. O’Connor, T.G.; Heron, J.; Golding, J.; Beveridge, M.; Glover, V. Maternal antenatal anxiety and children’s behavioural/emotional problems at 4 years: Report from the Avon Longitudinal Study of Parents and Children. Br. J. Psychiatry 2002, 180, 502–508.
73. Clavarino, A.M.; Mamun, A.A.; O’Callaghan, M.; Aird, R.; Bor, W.; O’Callaghan, F.; Williams, G.M.; Marrington, S.; Najman, J.M.; Alati, R. Maternal anxiety and attention problems in children at 5 and 14 years. J. Atten. Disord. 2010, 13, 658–667.
74. Robinson, M.; Oddy, W.H.; Li, J.; Kendall, G.E.; de Klerk, N.H.; Silburn, S.R.; Zubrick, S.R.; Newnham, J.P.; Stanley, F.J.; Mattes, E. Pre-and postnatal influences on preschool mental health: A large-scale cohort study. J. Child Psychol. Psychiatry 2008, 49, 1118–1128.
75. Hammed, M.; Lewis, A.J. Offspring of parents with schizophrenia: A systematic review of developmental features across childhood. Harv. Rev. Psychiatry In press, 2015.
76. Blankley, G.; Galbally, M.; Snellen, M.; Power, J.; Lewis, A.J. Borderline personality disorder in the perinatal period: Outcomes for mothers and infants. Australas. Psychiatry 2015, doi:10.1177/103 9856215590254.
77. Huizink, A.C.; Mulder, E.J.H.; Buitelaar, J.K. Prenatal stress and risk for psychopathology: Specific effects or induction of general susceptibility? Psychol. Bull. 2004, 130, 115–142.